Stay updated on Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the prior Revision: v3.4.1 entry and the funding-status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:50:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about the government funding lapse and NIH Clinical Center status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:29:33.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added UI elements and metadata labels (glossary, Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted) along with No FEAR Act Data and Revision: v3.4.0; removed corresponding older items (Results First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and older revision reference (Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-28T06:08:27.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is displayed, replacing the previous v3.3.3. This appears to be a minor version update with no visible changes to study details or page functionality.
    Difference
    0.1%
    Check dated 2026-01-14T02:44:17.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing sites in California, New Jersey, New York, and Texas. Removed the prior state-specific location headings for California, New Jersey, New York, and Texas (Revision: v3.3.3).
    Difference
    0.6%
    Check dated 2025-12-23T17:23:23.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page now displays a revised version label: Revision: v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:47:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.